417 related articles for article (PubMed ID: 29942318)
1. Mucosal-Associated Invariant T Cells in Autoimmune Diseases.
Chiba A; Murayama G; Miyake S
Front Immunol; 2018; 9():1333. PubMed ID: 29942318
[TBL] [Abstract][Full Text] [Related]
2. Mucosal-Associated Invariant T Cells Expressing the TRAV1-TRAJ33 Chain Are Present in Pigs.
Xiao X; Li K; Ma X; Liu B; He X; Yang S; Wang W; Jiang B; Cai J
Front Immunol; 2019; 10():2070. PubMed ID: 31552029
[TBL] [Abstract][Full Text] [Related]
3. Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child.
Ghazarian L; Caillat-Zucman S; Houdouin V
Front Immunol; 2017; 8():1837. PubMed ID: 29326714
[TBL] [Abstract][Full Text] [Related]
4. The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity.
Napier RJ; Adams EJ; Gold MC; Lewinsohn DM
Front Immunol; 2015; 6():344. PubMed ID: 26217338
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of mucosal-associated invariant T cells and their roles in immune diseases.
Chiba A; Murayama G; Miyake S
Int Immunol; 2021 Nov; 33(12):775-780. PubMed ID: 34508634
[TBL] [Abstract][Full Text] [Related]
6. MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.
Suliman S; Murphy M; Musvosvi M; Gela A; Meermeier EW; Geldenhuys H; Hopley C; Toefy A; Bilek N; Veldsman A; Hanekom WA; Johnson JL; Boom WH; Obermoser G; Huang H; Hatherill M; Lewinsohn DM; Nemes E; Scriba TJ
J Immunol; 2019 Dec; 203(11):2917-2927. PubMed ID: 31611259
[TBL] [Abstract][Full Text] [Related]
7. Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases.
Rouxel O; Lehuen A
Immunol Cell Biol; 2018 Jul; 96(6):618-629. PubMed ID: 29405379
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
9. Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease.
Hinks TS
Immunology; 2016 May; 148(1):1-12. PubMed ID: 26778581
[TBL] [Abstract][Full Text] [Related]
10. New insights into MAIT cells in autoimmune diseases.
Fan Q; Nan H; Li Z; Li B; Zhang F; Bi L
Biomed Pharmacother; 2023 Mar; 159():114250. PubMed ID: 36652733
[TBL] [Abstract][Full Text] [Related]
11. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
[TBL] [Abstract][Full Text] [Related]
12. Mucosal-Associated Invariant T Cell Levels Are Reduced in the Peripheral Blood and Lungs of Children With Active Pulmonary Tuberculosis.
Malka-Ruimy C; Ben Youssef G; Lambert M; Tourret M; Ghazarian L; Faye A; Caillat-Zucman S; Houdouin V
Front Immunol; 2019; 10():206. PubMed ID: 30853958
[TBL] [Abstract][Full Text] [Related]
13. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
14. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
[TBL] [Abstract][Full Text] [Related]
15. Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus.
Chiba A; Tamura N; Yoshikiyo K; Murayama G; Kitagaichi M; Yamaji K; Takasaki Y; Miyake S
Arthritis Res Ther; 2017 Mar; 19(1):58. PubMed ID: 28288675
[TBL] [Abstract][Full Text] [Related]
16. A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus.
Murayama G; Chiba A; Suzuki H; Nomura A; Mizuno T; Kuga T; Nakamura S; Amano H; Hirose S; Yamaji K; Suzuki Y; Tamura N; Miyake S
Front Immunol; 2019; 10():2681. PubMed ID: 31849932
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
18. Emerging Roles of Mucosal-Associated Invariant T Cells in Rheumatology.
Li Y; Du J; Wei W
Front Immunol; 2022; 13():819992. PubMed ID: 35317168
[TBL] [Abstract][Full Text] [Related]
19. [MAIT cells in autoimmunity].
Miyake S
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(5):393-8. PubMed ID: 23124081
[TBL] [Abstract][Full Text] [Related]
20. Diverse MR1-restricted T cells in mice and humans.
Koay HF; Gherardin NA; Xu C; Seneviratna R; Zhao Z; Chen Z; Fairlie DP; McCluskey J; Pellicci DG; Uldrich AP; Godfrey DI
Nat Commun; 2019 May; 10(1):2243. PubMed ID: 31113973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
